S100P is expressed in several kinds of malignant tumors. Intracellular S100P interacts with ezrin, and extracellular S100P activates the receptor for advanced glycation end products. However, little is known about the biological significance of S100P and related proteins in cholangiocarcinoma. Biliary intraepithelial neoplasia (BilIN) is a precursor lesion of hilar or perihilar cholangiocarcinoma. We examined S100P, ezrin, and the receptor for advanced glycation end product expression in 39 BilIN and 110 intrahepatic cholangiocarcinoma (ICC) cases, and analyzed its relationship with clinicopathologic factors and outcomes. S100P expression increased from reactive epithelium to low-grade BilIN to high-grade BilIN. S100P and ezrin expression rates in perihilar-type ICC were higher than those in peripheral-type ICC (P<0.0001, P = 0.0008, respectively). S100P nuclear expression in peripheral-type ICC significantly correlated with vascular invasion (P = 0.0209), lymphatic invasion (P = 0.0003), and lymph node metastasis (P = 0.003). S100P and ezrin expression was significantly correlated. S100P-positive and ezrin-positive cases indicate shorter survival in survival analysis of the peripheral type (P = 0.001, P = 0.0728, respectively). Our results suggest that S100P-ezrin signaling has different roles of carcinogenesis of perihilar ICC and an aggressive course of peripheral ICC.
T he S100 proteins contain 2 Helix-E and Helix-F loophand calcium-binding motifs that mediate Ca 2+dependent signal transduction. S100 proteins are localized in the nucleus and/or the cytoplasm of a wide range of cells, and are involved in the regulation of cell cycle progression and differentiation. 14 S100P protein is a small isoform of the S100 protein family and is isolated from the human placenta. 10 Overexpression of S100P has been detected in several tumors, including pancreatic, 6, 13, 26, 29, 37 colon, 17 breast, 18 prostate, 9 lung, 32 and ovarian cancers. 34 S100P functions as both extracellular and intracellular signaling molecules. Intracellular S100P can interact with the cytoskeletal protein ezrin by Ca 2+ -dependent regulation. 24 Ezrin is a member of the ERM (ezrin/radixin/ moesin) family, linking the plasma membrane and the actin cytoskeleton. 36 It also plays a role in the regulation of cell migration and cell proliferation. 7, 39 In several human malignant tumors, ezrin has been implicated in tumor cell metastasis and malignant progression. 4, 5, 15, 16, 23, 42 Extracellular S100P can activate receptors for advanced glycation end products (RAGE), which is known as a multiligand transmembrane receptor of the immunoglobulin superfamily. 5, 20, 27 RAGE is widely expressed in normal tissues, 12 and has been considered to affect the characteristic differences in various cancer cells. 21, 25, 27, 35 Recent studies have shown that S100P-RAGE signaling plays a major role in tumor development. 5, 6, 17 Intrahepatic cholangiocarcinoma (ICC) shows the second most common primary liver cancer. Despite recent advances, the molecular mechanisms involved in carcinogenesis and the development of ICC remain poorly understood. Biliary intraepithelial neoplasia (BilIN) is considered to be a precursor or noninvasive lesion of invasive cholangiocarcinoma of the hilar or perihilar region. 40 Lin et al 26 have observed that S100P is overexpressed in 90% of pancreatic intraepithelial neoplasia cases, 100% of pancreatic adenocarcinoma cases, and 61% of cholangiocarcinoma cases.
In this study, we assessed the expression of S100P, ezrin, and RAGE in BilIN and invasive ICC, and investigated its role in cholangiocarcinogenesis and tumor progression.
MATERIALS AND METHODS

Tissue Samples
Tumors and biliary lesions of the study were surgically resected and diagnosed at the Department of Anatomic Pathology of Kyushu University from 1985 to 2008. Our study protocol conformed to the ethics guidelines of the 1975 Declaration of Helsinki. For strict privacy protection, identifying information for all samples was removed before analysis. We reviewed sections from 45 cases of hepatolithiasis and 5 cases of primary sclerosing cholangitis, and we selected the biliary reactive epithelium (n = 11, hepatolithiasis) and BilIN (n = 39, 34 cases of hepatolithiasis and 5 cases of primary sclerosing cholangitis). The histopathologic definition of BilIN was based on the classification proposed by Zen et al. 41 Reactive epithelium was defined as the mildly hyperplastic epithelium with intraepithelial neutrophils and lymphocytic infiltration, lacking a definite disturbance of cell polarity (Fig. 1A ). BilIN-1 showed mild cellular atypia with enlarged nuclei and a minimal disturbance of cell polarity (n = 20, Fig. 1B ). BilIN-2 showed evident cellular atypia with a focal disturbance of cell polarity (n = 12, Fig. 1E ). BilIN-3 showed definite cellular atypia, nuclear pleomorphism, or complete loss of cell polarity (n = 7, Fig. 1F ). BilIN lesion and reactive epithelium were graded by 2 pathologists (S.A. and Y.M.), respectively. Then, we discussed the grade of the lesion. The definition of ICCs was based on the classification proposed by the World Health Organization, 38 and 110 cases of invasive ICC were reviewed. The ICCs were divided into the perihilar type (n = 41,
Representative cases of reactive epithelium (A), BilIN-1 (B), BilIN-2 (E), and BilIN-3 (F) by Hematoxylin and Eosin stain. S100P expression was observed in infiltrating neutrophils, but not in the reactive epithelium (C). S100P expression was observed only in the cytoplasm of BilIN-1 (D), and BilIN-2 showed nuclear and cytoplasmic expression (G). Strong nuclear and cytoplasmic expressions of S100P were observed diffusely in BilIN-3 (H). . Perihilar-type ICC showed invasive tubular adenocarcinoma (A), and peripheral-type ICC showed moderately differentiated adenocarcinoma with irregular small tubules (B). Large tubular carcinoma of the perihilar-type was positive for S100P (nuclear and cytoplasmic) (C) and ezrin (E), but negative for RAGE (G). Small tubular carcinoma of the peripheral type was negative for S100P (D) and ezrin (F), but positive for RAGE (H). Fig. 2A ), which is involved in a large bile duct, or the peripheral type (n = 69, Fig. 2B ), which is involved in smaller than segmental branches based on gross and histologic classifications developed from an earlier study. 2 The median age of the patients with ICC was 64 years (range, 33 to 90 y); the group included 67 men and 43 women. The median tumor size was 4 cm (range, 1 to 12 cm). Vascular invasion, lymphatic invasion, and lymph node metastasis were observed in 75 cases (68%), 56 cases (51%), and 28 cases (25%) of ICC, respectively.
Immunohistochemical Staining and Evaluation
Tumor samples were fixed with 10% formaldehyde, embedded in paraffin, and sectioned into 4-mm-thick slices. Immunohistochemical staining was performed by the streptavidin-biotin-peroxidase method (Histofine, Nichirei, Tokyo). Primary antibodies used in this study were goat monoclonal anti-S100P (1:200 dilution; Santa Cruz Biotechnology), rabbit polyclonal anti-Ezrin (1:200 dilution; Cell signaling technology), and goat monoclonal anti-RAGE (1:500 dilution; Santa Cruz Biotechnology). After the inhibition of endogenous peroxidase in a 3% H 2 O 2methanol solution for 20 minutes and antigen retrieval [microwave irradiation in citrate buffer (pH6.0) for both antibodies], the sections were exposed to each primary antibody at 41C overnight. The sections were then reacted in 3,3 0 -diaminobenzidine, counterstained with hematoxylin, and mounted. Evaluation of the immunohistochemical results was scored by 2 pathologists (Y.M. and S.A.), without knowledge of the clinical data.
Immunohistochemical staining was evaluated in the area showing the highest degree of dysplasia in each BilIN. To evaluate the expression of ICC, representative fields, including cancer and noncancerous areas, were selected. The proportion of positive cells was semiquantitatively measured using the following scale according to the percentage of positive tumor cells: 0 ( <1% positive cells), 1+ (1% to 10% positive cells), 2+ (11% to 50% positive cells), 3+ (>51% positive cells). The expression of S100P in dysplastic or cancer cells was defined as positive when the nucleus or cytoplasm stained to show >11% dysplastic or cancer cells; both nuclear and cytoplasmic staining were separately evaluated. For the survival analysis of ICC cases, S100P total expression was classified into negative group (0/1+ nuclear expression and 0/1+ cytoplasmic expression) and positive group (2+/3+ nuclear expression and/or 2+/3+ cytoplasmic expression). The expression of RAGE and ezrin in dysplastic cells or cancer cells was defined as positive when the cytoplasm stained to show >11% tumor cells.
Statistical Analysis
Statistical analysis of group differences was carried out by the w 2 test, Fisher exact test, and Mann-Whitney U test. The Kaplan-Meier method was used for survival analysis, and a comparison was made based on the log-rank test. P<0.05 was considered to be statistically significant. 
RESULTS
Immunohistochemical Expression in Reactive Epithelium, BilIN, and Invasive ICC
Immunohistochemical scores and positive rates are summarized in Table 1 . S100P immunoreactivity was absent in the nucleus, but focally positive in the cytoplasm of reactive epithelium, whereas S100P was extensively observed in infiltrating neutrophils (Fig. 1C ). In 20 cases of BilIN-1, S100P was observed in the nucleus (3 of 20; 15%) and in the cytoplasm (9 of 20; 45%) ( Fig. 1D) . In 12 cases of BilIN-2, 9 (75%) cases of nuclear stain and 8 (67%) cases of cytoplasmic stain were observed (Fig. 1G) , and all 7 cases of BilIN-3 showed diffuse nuclear and cytoplasmic stains (Fig. 1H ). Nuclear and cytoplasmic S100P were observed in 28 of 41 (68%) and 23 of 41 (63%) of perihilar-type ICCs (Fig. 2C) , whereas they were observed in 8 of 69 (12%) and in 9 of 69 (13%) of peripheral-type ICCs (Fig. 2D ). Nuclear S100P expression increased from reactive epithelium to BilIN-2 ( Fig. 3A) . Cytoplasmic S100P expression gradually increased from reactive epithelium to BilIN-3 and decreased from BilIN-3 to the perihilar type ( Fig. 3B ). Nuclear and cytoplasmic S100P expression rate was significantly higher in the perihilar-type than in peripheral-type ICC (P<0.0001) (Figs. 3A, B) .
Positive staining for ezrin was observed in 4 of 11 (36%) cases of reactive epithelium, 5 of 20 (25%) cases of BilIN-1, 9 of 12 (75%) cases of BilIN-2, 6 of 7 (86%) cases of BilIN-3, 20 of 41 (49%) cases of perihilar-type ICC (Fig. 2E ), and 14 of 69 (20%) cases of peripheraltype ICC (Fig. 2F ). Ezrin expression of BilIN-2 was higher than that of BilIN-1 (P = 0.0004). Ezrin expression of the perihilar type was higher than that of the peripheral type (P = 0.0008, Fig. 3C ).
RAGE immunoreactivity was weakly observed in some peribiliary glands or liver parenchyma. RAGE expression was observed in 1 of 11 (9%) cases of reactive epithelium, 2 of 20 (10%) cases of BilIN-1, 3 of 12 (25%) cases of BilIN-2, none (0%) of the cases of BilIN-3, 7 of . Nuclear S100P expression was increased from reactive to BilIN-2. Cytoplasmic S100P expression was gradually increased from reactive epithelium to BilIN-3 and decreased from BilIN-3 to the perihilar type. Ezrin expression of BilIN-2 was higher than that of BilIN1. S100P and ezrin expression of the perihilar type were higher than those of the peripheral type.
Am J Surg Pathol Volume 35, Number 4, April 2011 S100P Expression in Intrahepatic Cholangiocarcinoma 41 (17%) cases of perihilar-type ICC (Fig. 2G) , and 17 of 69 (25%) cases of peripheral-type ICC (Fig. 2H, Fig. 3D ).
Immunohistochemical Results and Clinicopathologic Correlations in ICC
In perihilar-type ICC, no significant correlations were observed between clinicopathologic parameters and immunohistochemical expression ( Table 2 ). In peripheraltype ICC, S100P nuclear expression was significantly higher in cases with vascular invasion (P = 0.0209), lymphatic invasion (P = 0.0003), and lymph node metastasis (P = 0.003, Table 3 ). S100P cytoplasmic examination also shows positive statistical correlations with lymphatic invasion (P = 0.0231) and lymph node metastasis (P = 0.006, Table 3 ).
The nuclear and cytoplasmic expression of S100P in ICC correlated with ezrin expression (P = 0.004, P = 0.0248, respectively), whereas there was no statistical relationship between S100P expression and RAGE expression ( Table 4 ).
Protein Expression and Patient Outcomes
Patient survival was evaluated by follow-up for a mean period of 3.13 years. The survival rates for patients with ICC at 1, 3, and 5 years were 73.6%, 48.4%, and 34.2%, respectively. In patients with perihilar ICC, there was no statistical difference between the survival rate and 3 protein expressions (Figs. 4A, C, E) . The cancer-specific survival rates of peripheral-type ICC with positive total S100P expression were significantly lower than those of peripheral-type ICC with negative total S100P expression (P = 0.001, Fig. 4B ). Peripheral-type ICC with positive ezrin expression showed lower survival tendency than those with negative ezrin expression (P = 0.0728, Fig. 4D ), but there was no statistical difference between the survival rate and RAGE expression (P = 0.9952, Fig. 4F ). Perihilartype ICC (Figs. 5A, C) and peripheral-type ICC (Figs. 5B, D) show significant survival differences with respect to lymphatic invasion ( Fig. 5A , P = 0.0002; Fig. 5B , P< 0.0001) and nodal metastasis ( Fig. 5C , P = 0.0004; Fig. 5D , P<0.0001).
DISCUSSION
The only curative treatment for cholangiocarcinoma is complete surgical resection, and no beneficial roles were shown in chemoradiotherapy. The high expression of S100P has been regarded as a potential target molecule for therapeutic applications. 31 However, other studies have shown that S100P plays a critical role in resistance to chemotherapeutic agents. 5, 22 In this study, S100P was overexpressed in the aggressive peripheral-type ICC with lymphatic invasion and lymph node metastasis in surgical samples. Peripheral ICC with positive S100P showed poorer prognosis after surgery than those with negative S100P. Our results suggest that S100P plays a role in cell invasion and metastasis in peripheral ICC, as suggested in the studies involving pancreatic carcinoma cells. 6, 37 BilIN is premalignant or noninvasive lesions of perihilar-type ICC. 2,41 S100P and ezrin showed an increased protein expression from low-grade BilIN to high-grade BilIN. Our results suggest a critical role for S100P and ezrin in cholangiocarcinogenesis of the large bile duct. In contrast, peripheral-type ICC, which is located in the periphery of the liver and is suggestive of a lesion arising from the small biliary epithelium, showed low positivity for S100P and ezrin expression. The molecular mechanism of S100P overexpression in ICC remained unclear in our study. Interleukin-6 (IL-6) is increased in the serum of patients with cholangiocarcinoma, 28 and stimulates the growth of cholangiocarcinoma cells. 30 In addition, IL-6 is a potent inducer of S100P in prostate cancer. 19 Prostaglandin E2, which is expressed in hepatolithiasis, 33 can induce S100P. 11 Therefore, S100P may be upregulated by IL-6 or prostaglandin stimulation of inflammatory condition in carcinogenesis of perihilar cholangiocarcinoma.
The differences in positivity for S100P and ezrin between perihilar-type ICC and peripheral-type ICC support the concept of the different processes of carcinogenesis in the 2 types of ICC. 2 We have previously shown the significant biological differences between perihilar-type ICC and peripheral-type ICC in the expression of MUC5AC (mucus core protein), aquaporin-1 (water channel molecule), and intratumoral arterial vessel density. 1, 3 Together with the results indicating that >90% of pancreatic intraepithelial neoplasia and pancreatic invasive adenocarcinoma show positive S100P expression, 26 perihilartype ICC may have same carcinogenetic pathway in pancreatic adenocarcinoma. S100P overexpression was related to carcinogenesis or to the early development of pancreatic cancer. 26, 29 In contrast, S100P expression of prostatic cancer 9 and ovarian cancer 34 was associated with aggressive tumor behavior and poor prognosis. In addition, ezrin expression of hepatocellular carcinoma was associated with advanced stage and poor prognosis. 23 Peripheral-type ICC showed higher background of chronic hepatitis and cirrhosis, and similar behavior with hepatocellular carcinoma. 2 These results suggest that the role of S100P and ezrin was different in the kinds of malignant tumor and 2 types of ICC.
Although extracellular S100P stimulates cell proliferation by RAGE, 5 Austermann et al 7, 8 have shown S100Pmediated activation of ezrin and suggested that the interaction between S100P and ezrin promotes a migration of tumor cells and metastatic potential. Our study has shown that S100P expression is significantly correlated with ezrin expression, not with RAGE expression, in ICC tissue. RAGE expression tended to be higher in peripheral-type ICC than perihilar-type ICC. As S100P protein was localized in the cytoplasm and/or nucleus of cancer cells, the hypothesis that extracellular S100P induces RAGE activation, was not confirmed in the resected specimen of ICC.
In conclusion, S100P and ezrin were found to be expressed in gradual increase from reactive epithelium to premalignant biliary neoplasia and invasive cholangiocarcinoma of the perihilar type. S100P and ezrin seem to contribute to tumor invasiveness and metastasis in peripheral ICC. Our results suggest that S100P-ezrin signaling has different roles of carcinogenesis of perihilar ICC and an aggressive tumor behavior of peripheral ICC. 
